Therefore, this study aimed to assess the safety of utilizing miR-130b-MVs for obesity treatment, revealing an upward trend in plasma levels of IL-6 and TNF-α after miR-130b-MV injection. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.